Welcome to our dedicated page for Marimed news (Ticker: MRMD), a resource for investors and traders seeking the latest updates and insights on Marimed stock.
MariMed Inc. reports news on its multi-state cannabis operating platform, including cultivation, production, branded consumer products and retail dispensaries. Company updates commonly cover financial results, earnings-call schedules, wholesale distribution, branded product activity and retail operations tied to names such as Betty's Eddies, Bubby’s Baked, InHouse, Nature’s Heritage, Vibations and Thrive Dispensary.
Recurring developments also include capital-structure actions, preferred-stock obligations, hemp-derived THC product launches, cannabis regulatory commentary and community initiatives associated with the company's dispensary and brand portfolio.
MariMed, Inc. (OTCQX: MRMD) will release its fourth quarter and full year 2021 financial results on March 16, 2022, after market close. A conference call to discuss these results is scheduled for March 17, 2022, at 8:00 a.m. ET. The call will be accessible via MariMed's Investor Relations website, where a playback will be available for 30 days. MariMed is recognized as a leading multi-state cannabis operator, focusing on high-quality products and consistent growth through its management team and proprietary formulations.
Summary not available.
MariMed (OTCQX: MRMD) has expanded its reach into Delaware, where its cannabis brands are now available following new regulations in the state's Medical Marijuana program. The company has signed an enhanced licensing agreement with First State Compassion Center (FSC), allowing FSC to exclusively produce and distribute MariMed's popular cannabis edibles, including Betty’s Eddies® and Bubby’s Baked™. This expansion marks the availability of MariMed’s products in six states plus Puerto Rico, strengthening its market presence.
MariMed, Inc. (OTCQX: MRMD) has signed a definitive agreement to acquire Green Growth Group, Inc., holder of a provisional Cannabis Craft License in Illinois. This acquisition will enhance MariMed's cannabis operations in the state by integrating cultivation, manufacturing, and distribution capabilities. The transaction supports MariMed's strategy to improve revenue and profit margins by expanding in high-growth markets. Additionally, the company plans to develop a facility for cultivation and production of its proprietary cannabis products, leveraging Illinois's $1.8 billion cannabis market.
MariMed Inc. (OTCQX: MRMD) has entered into a definitive agreement to acquire Kind Therapeutics U.S.A., LLC for $20 million, marking a strategic expansion into Maryland’s cannabis market. The acquisition is subject to regulatory approvals and aims to consolidate MariMed's operations, enhancing its growth trajectory following two years of over 100% revenue growth. Kind holds essential cannabis licenses and operates from a 180,000 sq. ft. facility developed by MariMed, contributing to Maryland’s thriving cannabis industry, which serves over 139,000 registered patients.
Summary not available.
Summary not available.
MariMed, Inc. (MRMD) reported impressive financial results for Q3 2021, with revenue of $33.2 million, a 147% increase year-over-year. The adjusted EBITDA reached $12.9 million, marking a 213% increase compared to the same quarter last year. Net income rose to $2.1 million, up 25% year-over-year. The company also maintained working capital of $27.3 million. MariMed’s retail operations in Illinois and Massachusetts saw revenue growth of 207% year-over-year, demonstrating strong performance despite an industry-wide slowdown. Full-year guidance remains at $118 million in revenue and $42 million in adjusted EBITDA.
Summary not available.
MariMed, Inc. (OTCQX: MRMD), a multi-state cannabis operator, announced it will release its third quarter 2021 financial results on November 15, 2021, after market close. Management will hold a conference call on November 16, 2021, at 8:00 a.m. EDT to discuss these results. The call will be accessible via the company's Investor Relations website, with a playback available for 30 days. MariMed is focused on providing high-quality cannabis products and has developed a robust portfolio, including brands like Betty's Eddies® and Nature’s Heritage™.